Unknown

Dataset Information

0

Increased Purinergic Responses Dependent on P2Y2 Receptors in Hepatocytes from CCl4-Treated Fibrotic Mice.


ABSTRACT: Inflammatory and wound healing responses take place during liver damage, primarily in the parenchymal tissue. It is known that cellular injury elicits an activation of the purinergic signaling, mainly by the P2X7 receptor; however, the role of P2Y receptors in the onset of liver pathology such as fibrosis has not been explored. Hence, we used mice treated with the hepatotoxin CCl4 to implement a reversible model of liver fibrosis to evaluate the expression and function of the P2Y2 receptor (P2Y2R). Fibrotic livers showed an enhanced expression of P2Y2R that eliminated its zonal distribution. Hepatocytes from CCl4-treated mice showed an exacerbated ERK-phosphorylated response to the P2Y2R-specific agonist, UTP. Cell proliferation was also enhanced in the fibrotic livers. Hepatic transcriptional analysis by microarrays, upon CCl4 administration, showed that P2Y2 activation regulated diverse pathways, revealing complex action mechanisms. In conclusion, our data indicate that P2Y2R activation is involved in the onset of the fibrotic damage associated with the reversible phase of the hepatic damage promoted by CCl4.

SUBMITTER: Velazquez-Miranda E 

PROVIDER: S-EPMC7177255 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Increased Purinergic Responses Dependent on P2Y2 Receptors in Hepatocytes from CCl<sub>4</sub>-Treated Fibrotic Mice.

Velázquez-Miranda Erandi E   Molina-Aguilar Christian C   González-Gallardo Adriana A   Vázquez-Martínez Olivia O   Díaz-Muñoz Mauricio M   Vázquez-Cuevas Francisco G FG  

International journal of molecular sciences 20200326 7


Inflammatory and wound healing responses take place during liver damage, primarily in the parenchymal tissue. It is known that cellular injury elicits an activation of the purinergic signaling, mainly by the P2X7 receptor; however, the role of P2Y receptors in the onset of liver pathology such as fibrosis has not been explored. Hence, we used mice treated with the hepatotoxin CCl<sub>4</sub> to implement a reversible model of liver fibrosis to evaluate the expression and function of the P2Y2 rec  ...[more]

Similar Datasets

2019-09-30 | E-MTAB-8302 | biostudies-arrayexpress
| S-EPMC5489490 | biostudies-literature
| S-EPMC6709641 | biostudies-literature
2019-07-04 | GSE133795 | GEO
| S-EPMC3080971 | biostudies-literature
| S-EPMC8398939 | biostudies-literature
| S-EPMC5473841 | biostudies-literature
| S-EPMC9138794 | biostudies-literature
| S-EPMC10765495 | biostudies-literature
| S-EPMC5579179 | biostudies-literature